IL-17 plays a significant role in chronic inflammation and ECM degradation in IDD. Targeting IL-17 and it’s signaling pathways could reduce inflammation and protect against tissue damage. The gene discussed is IL17A; the disease is intervertebral disk degenerative disorder.